Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...

WASHINGTON — The White House announced the start of “Phase Two” of President Trump’s Gaza peace process Wednesday — despite Hamas refusing to disarm. The administration entered the new phase ...

The biggest stories of the day delivered to your inbox.

Workouts I’m a personal trainer who works with seniors: These are the 6 exercises I wish everyone over 60 would do to improve their strength and balance, and prevent falls Workouts I’m a personal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...

Woodside’s top executive is very bullish about a second development phase on its flagship Sangomar deepwater project offshore Senegal, which is could involve a potential 30-well subsea system.

AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a phase 2 study. The U.K.-based pharma had been evaluating the antisense ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...